Measurement of medial temporal lobe atrophy in diagnosis of Alzheimer's disease.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 8093400)

Published in Lancet on January 09, 1993

Authors

M J de Leon, J Golomb, A Convit, S DeSanti, T D McRae, A E George

Articles by these authors

The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA (1997) 5.09

Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86

The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40

Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging (2000) 2.80

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68

Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66

Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia (2007) 2.60

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48

The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44

Hippocampal volume losses in minimally impaired elderly. Lancet (1995) 2.26

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24

Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia (2010) 2.20

Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci (2007) 2.11

Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08

Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry (1989) 2.07

Testicular fixation following torsion of the spermatic cord--does it guarantee prevention of recurrent torsion events? J Urol (2006) 2.02

Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02

Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol (1999) 1.93

Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92

MRI of entorhinal cortex in mild Alzheimer's disease. Lancet (1999) 1.86

MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med (2004) 1.77

Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67

CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62

Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand (2010) 1.57

Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications. Isr Med Assoc J (2001) 1.50

Mini-Mental State exam scores vary with education in blacks and whites. J Am Geriatr Soc (1991) 1.50

Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol (1993) 1.49

Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol (2000) 1.47

Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci (1997) 1.39

Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res (2001) 1.38

Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q (1993) 1.33

Hippocampal formation size predicts declining memory performance in normal aging. Neurology (1996) 1.33

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol (1992) 1.33

Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology (2004) 1.31

Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem (1999) 1.31

Cortisol differentially affects memory in young and elderly men. Behav Neurosci (2001) 1.19

Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol (1986) 1.18

HIV seroprevalence and risk behaviors in psychiatric inpatients. Psychiatry Res (1991) 1.18

In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann N Y Acad Sci (1996) 1.17

Intracranial aneurysm on a persistent primitive trigeminal artery. Case report. J Neurosurg (1971) 1.15

Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett (2002) 1.14

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab (1983) 1.13

MRI volume of the amygdala: a reliable method allowing separation from the hippocampal formation. Psychiatry Res (1999) 1.13

Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol (1983) 1.13

Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res (1998) 1.12

Pure motor hemiplegia with occlusion of the extracranial carotid artery. J Neurol Sci (1973) 1.07

Alzheimer's disease: longitudinal CT studies of ventricular change. AJR Am J Roentgenol (1989) 1.05

Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol (2010) 1.04

Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab (1997) 1.04

Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. Int Psychogeriatr (1997) 1.04

Atypical computed tomography features of intracranial meningioma: radiological-pathological correlation in a series of 131 consecutive cases. Radiology (1980) 1.02

MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. AJNR Am J Neuroradiol (1998) 1.01

C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation (2008) 1.00

Positron emission tomography and computed tomography assessments of the aging human brain. J Comput Assist Tomogr (1984) 1.00

Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI. Brain Res Brain Res Protoc (2002) 0.99

Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet (1988) 0.98

Reduced incidence of left-handedness in clinically diagnosed dementia of the Alzheimer type. Neurobiol Aging (1986) 0.98